Navigation Links
Scarguard Labs, LLC Gains Approval to Sell Scarguard in Canada
Date:2/23/2011

GREAT NECK, N.Y., Feb. 23, 2011 /PRNewswire/ -- Scarguard Labs, LLC, a closely held company specializing in the treatment of scars, psoriasis and other dermatological problems through the use of multi-technology drugs enhanced by a proprietary contact delivery system, announced today that they have received approval from Health Canada to sell Scarguard to physicians and consumers throughout Canada.

"We are very pleased to gain approval for retail in our first international market," stated Dr. Joel Studin, Chairman and CEO of Scarguard Labs. "The Canadian market provides an opportunity for Scarguard to increase overall sales and profits by an estimated 15% while driving brand awareness with physicians as well as consumers."

About Scarguard Labs, LLC.Scarguard Labs, LLC is a closely held pharmaceutical company specializing in dermatological medications employing an internationally patented delivery system designed to enhance drug effectiveness utilizing a multi-technology approach. Our flagship product, Scarguard, is the most frequently dispensed in plastic surgery offices product for scars since 2001. In addition, it can be found in most pharmacies, drug distributors, mass merchants, and major grocery chains throughout the United States. We have multiple topical prescription and non-prescription drugs for eczema, psoriasis, and many other dermatological conditions in the marketplace, or in varying stages of development. For more information, please visit our website at www.scarguard.comCompany Contact:Richard E. PinoChief Financial Officer / Investor Relations Scarguard Labs, LLC 516-482-8050richard@scarguard.com
'/>"/>

SOURCE Scarguard Labs, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
2. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
3. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
4. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
5. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
6. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
7. GeoVax Labs, Inc. Provides Clinical Studies Update
8. GeoVax Labs, Inc. Announces Resignation of Director
9. GeoVax Labs, Inc. Announces First Quarter Financial Results
10. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
11. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... Michael Zasloff , MD, Ph.D., Professor ... Medicine, and Founder, Chairman and CEO of Enterin Inc. ... helped clarify the function of alpha-Synuclein (aS), the protein ... Denise Barbut , MD, FRCP, Co-Founder, President and ... of the study. Published in the Journal ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... Bock UK Ltd (Bock) announced a strategic partnership where Bock will ... enzyme technology, OPTIMASH® AD-100, has been shown to help biogas producers in the ...
(Date:6/28/2017)... ... June 28, 2017 , ... Studies indicate that replacing damaged brain cells with ... Parkinson’s disease. But what has not been determined is the optimal stage during differentiation ... results. , A new study coming out of Singapore, recently published in STEM CELLS ...
(Date:6/27/2017)... , ... June 27, 2017 , ... Biodex Medical Systems, ... ambulation aid in one device. This assistive aid lifts patients safely from a seated ... and motorized lift mechanics. The Mobility Assist is the latest in a line of ...
Breaking Biology Technology:
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
Breaking Biology News(10 mins):